Published in Eur J Hum Genet on January 23, 2013
Revealing the incidentalome when targeting the tumor genome. JAMA (2013) 1.27
Public attitudes towards genomic risk profiling as a component of routine population screening. Genome (2013) 0.83
Personalised Medicine and Scarce Resources: A Discussion of Ethical Chances and Challenges from the Perspective of the Capability Approach. Public Health Genomics (2016) 0.75
CJCheck Stage 1: development and testing of a checklist for reporting community juries - Delphi process and analysis of studies published in 1996-2015. Health Expect (2016) 0.75
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
Whatever happened to qualitative description? Res Nurs Health (2000) 24.65
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol (2006) 16.25
National Institute for Clinical Excellence and its value judgments. BMJ (2004) 8.97
What's in a name? Qualitative description revisited. Res Nurs Health (2010) 5.17
Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe. Eur J Hum Genet (2010) 2.38
The need for public engagement in choosing health priorities. CMAJ (2010) 2.35
Genomics and the continuum of cancer care. N Engl J Med (2011) 2.26
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer (2007) 2.03
Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey. BMJ (2009) 2.02
Bringing 'the public' into health technology assessment and coverage policy decisions: from principles to practice. Health Policy (2006) 1.91
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin (2011) 1.90
Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care (2005) 1.80
The public health genomics translation gap: what we don't have and why it matters. Public Health Genomics (2012) 1.50
Citizens' values regarding research with stored samples from newborn screening in Canada. Pediatrics (2012) 1.48
Examining the role of context in the implementation of a deliberative public participation experiment: results from a Canadian comparative study. Soc Sci Med (2007) 1.45
Structuring public engagement for effective input in policy development on human tissue biobanking. Public Health Genomics (2010) 1.45
Australian study on public knowledge of human genetics and health. Public Health Genomics (2008) 1.45
Autonomy versus futility? Barriers to good clinical practice in end-of-life care: a Queensland case. Med J Aust (2012) 1.44
Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician (2009) 1.40
Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet (2012) 1.35
Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice? Health Expect (2011) 1.29
What is public deliberation? Hastings Cent Rep (2012) 1.13
Wanted: a new ethics field for health policy analysis. Health Care Anal (2005) 1.10
Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med (2011) 1.08
Genome Medicine: past, present and future. Genome Med (2011) 1.03
Implementing a public deliberative forum. Hastings Cent Rep (2012) 1.01
A Community's Awareness and Perceptions of Genomic Medicine. Public Health Genomics (2009) 1.00
Personalised care and the genome. BMJ (2012) 0.96
Can genomics bend the cost curve? JAMA (2012) 0.94
Personalized medicine and access to health care: potential for inequitable access? Eur J Hum Genet (2012) 0.92
Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario. Int J Technol Assess Health Care (2009) 0.90
Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet (2010) 0.82
Personalized medicine: a transformative approach is needed. CMAJ (2009) 0.81
What is good public deliberation? Hastings Cent Rep (2012) 0.79
NICE should engage generalists--public and professional. BMJ (2009) 0.77
A defence of the requirement to seek consent to withhold and withdraw futile treatments. Med J Aust (2012) 0.76
How can research organizations more effectively transfer research knowledge to decision makers? Milbank Q (2003) 9.82
Examining the role of health services research in public policymaking. Milbank Q (2002) 6.45
Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med (2003) 6.00
Public participation in health care priority setting: A scoping review. Health Policy (2009) 2.52
'The public is too subjective': public involvement at different levels of health-care decision making. Soc Sci Med (2002) 2.19
Alternatives to project-specific consent for access to personal information for health research: what is the opinion of the Canadian public? J Am Med Inform Assoc (2007) 1.98
Deliberative dialogues as a mechanism for knowledge translation and exchange in health systems decision-making. Soc Sci Med (2012) 1.94
What is important to continuity in home care?. Perspectives of key stakeholders. Soc Sci Med (2004) 1.93
Bringing 'the public' into health technology assessment and coverage policy decisions: from principles to practice. Health Policy (2006) 1.91
Research use in children's mental health policy in Canada: maintaining vigilance amid ambiguity. Soc Sci Med (2005) 1.77
Joining the conversation: newspaper journalists' views on working with researchers. Healthc Policy (2005) 1.34
Alternatives to project-specific consent for access to personal information for health research: insights from a public dialogue. BMC Med Ethics (2008) 1.33
Participation in health care priority-setting through the eyes of the participants. J Health Serv Res Policy (2002) 1.30
Evaluating deliberative dialogues focussed on healthy public policy. BMC Public Health (2014) 1.27
How contexts and issues influence the use of policy-relevant research syntheses: a critical interpretive synthesis. Milbank Q (2013) 1.25
The policy analysis of 'values talk': lessons from Canadian health reform. Health Policy (2004) 1.23
Are we expecting too much from print media? An analysis of newspaper coverage of the 2002 Canadian healthcare reform debate. Soc Sci Med (2006) 1.22
Utilization of nurse practitioners to increase patient access to primary healthcare in Canada--thinking outside the box. Nurs Leadersh (Tor Ont) (2010) 1.22
Introducing patients' and the public's perspectives to health technology assessment: A systematic review of international experiences. Int J Technol Assess Health Care (2011) 1.17
What is public deliberation? Hastings Cent Rep (2012) 1.13
"It all depends": conceptualizing public involvement in the context of health technology assessment agencies. Soc Sci Med (2010) 1.12
Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med (2011) 1.08
Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst (2013) 1.05
Family Perceptions of End-of-Life Care in long-term care facilities. J Palliat Care (2004) 1.03
From rhetoric to reality: including patient voices in supportive cancer care planning. Health Expect (2005) 1.03
Knowledge into action? understanding ideological barriers to addressing health inequalities at the local level. Health Policy (2006) 0.93
The integration of citizens into a science/policy network in genetics: governance arrangements and asymmetry in expertise. Health Expect (2010) 0.91
Framing incremental expansions to public health insurance systems: the case of Canadian pharmacare. J Health Polit Policy Law (2014) 0.91
Why and when should we use public deliberation? Hastings Cent Rep (2012) 0.91
Mental health service delivery in Ontario, Canada: how do policy legacies shape prospects for reform? Health Econ Policy Law (2007) 0.89
Development of a framework for effective community engagement in Ontario, Canada. Health Policy (2010) 0.89
Factors enabling advanced practice nursing role integration in Canada. Nurs Leadersh (Tor Ont) (2010) 0.86
Advanced practice nursing in Canada: overview of a decision support synthesis. Nurs Leadersh (Tor Ont) (2010) 0.83
Moving cautiously: Public involvement and the health technology assessment community. Int J Technol Assess Health Care (2011) 0.80
Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care (2013) 0.75
The visible politics of the privatization debate in Quebec. Healthc Policy (2012) 0.75